HealthcareServices

Global Desmoid Tumors Market Performance Report: Global Trends 2026–2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the desmoid tumors market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Desmoid Tumors Market between 2026 and 2030?

The market for desmoid tumors has experienced significant expansion in recent years. It is projected to expand from $3.15 billion in 2025 to $3.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. Historically, this growth has been influenced by factors such as limited awareness of rare tumors, a predominant reliance on surgery, the absence of targeted drug therapies, the prevalence of hospital-based oncology care, and challenges in timely diagnosis.

The desmoid tumors market size is projected to experience substantial growth in the coming years, with expectations to reach $4.42 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This expansion during the forecast period can be attributed to advancements in molecular therapies, the increasing development of rare disease pipelines, a rise in clinical trials, improvements in diagnostic imaging, and the expansion of specialty centers. Significant trends during this period are expected to include a shift towards non-surgical management, a growing adoption of targeted molecular therapies, the development of watchful waiting strategies, the broadening of multidisciplinary care models, and an intensified focus on rare disease research.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Desmoid Tumors Market?

The desmoid tumor market is expected to expand going forward, driven by the increasing number of cancer cases. Cancer describes a range of diseases characterized by the uncontrolled growth and spread of aberrant cells throughout the body, capable of infiltrating and damaging surrounding tissues and organs. The global surge in cancer diagnoses has heightened the demand for effective and advanced chemotherapeutic agents, which in turn has favorably influenced the desmoid tumor market. As an illustration, the National Health Service (NHS), a UK-based government health agency, reported in October 2025 that there were 354,820 new cancer diagnoses in 2023, averaging 972 per day, representing an increase of 8,605 compared to 2022. Consequently, the rising instances of cancer are propelling the growth of the desmoid tumor market.

How Is The Desmoid Tumors Market Organized Into Various Segments?

The desmoid tumors market covered in this report is segmented –

1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments

2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis

3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users

Subsegments:

1) By Surgery: Wide Excision, Minimally Invasive Surgery

2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy

3) By Anti-Inflammatory Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Corticosteroids

4) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors

5) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy

6) By Novel Molecular-Targeted Therapy: Tyrosine Kinase Inhibitors

7) By Other Treatments: Watchful Waiting, Physical Therapy, Pain Management Strategies

What Upcoming Trends Are Likely To Define The Future Path Of The Desmoid Tumors Market?

Major companies in the desmoid tumors market are focused on developing innovative drugs, like nirogacestat, for treating desmoid tumors to more effectively meet the needs of their current consumers. Nirogacestat functions as an oral, small-molecule gamma-secretase inhibitor. For instance, in February 2023, SpringWorks Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) acceptance and priority review for their new drug application (NDA) concerning nirogacestat for adults with desmoid tumors. Nirogacestat is believed to operate by inhibiting the production of notch proteins, which can lead to the demise of tumor cells. Desmoid tumors themselves produce elevated levels of notch protein, thought to contribute to their growth. Moreover, nirogacestat offers patients a new therapeutic choice that could potentially improve results.

Who Are The Core Companies Influencing Trends In The Desmoid Tumors Market?

Major companies operating in the desmoid tumors market are Pfizer Inc., F.Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Amgen Inc., Eisai Limited, Incyte Corporation, Ipsen Biopharmaceuticals Inc., BeiGene Ltd., Janssen Biotech Inc., Blueprint Medicines Corporation, Debiopharm Group, Clovis Oncology Inc., SpringWorks Therapeutics Inc., Loxo Oncology Inc., Mirati Therapeutics Inc., Iterion Therapeutics Inc., Recepta Pharmaceuticals Inc., Cellestia Biotech AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report

Which Regions Are Projected To Dominate The Desmoid Tumors Market In The Coming Years?

North America was the largest region in the desmoid tumors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the desmoid tumors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Desmoid Tumors Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13228&type=smp

Browse Through More Reports Similar to the Global Desmoid Tumors Market 2026, By The Business Research Company

Penile Cancer Market Report 2026

https://www.thebusinessresearchcompany.com/report/penile-cancer-global-market-report

Desiccants Market Report 2026

https://www.thebusinessresearchcompany.com/report/desiccants-global-market-report

Cancer Cachexia Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-cachexia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795